0 My Account

Fetal Effects of Estrogens, Progestogens, and Diethylstilbestrol

Kaufman RH et al., 1998

Abstract

No abstract available for this article.

Topics

Pregnancy > Outcomes > ComplicationsReproductive Endocrinology > Estrogen > Clinical EffectsReproductive Endocrinology > Progesterone > Clinical Effects
diethylstilbestrol pregnancy exposure, DES fetal effects, estrogen exposure in pregnancy, progestogen safety pregnancy, hormone medication pregnancy risks, prenatal hormone exposure outcomes, medication safety reproductive health, synthetic estrogen fetal development

Cite this article

Kaufman, R. H., & Simpson, J. L. (1998). *Fetal Effects of Estrogens, Progestogens, and Diethylstilbestrol*.

Related articles

Platelet Rich Plasma in Gynecology-Discovering Undiscovered-Review
Streit-Ciećkiewicz D et al., 2022 Open Access International Journal of Environmental Research and Public Health

Regenerative medicine combines elements of tissue engineering and molecular biology aiming to support the regeneration and repair processes of damaged tissues, cells and organs. The most commonly used...

Reproductive Endocrinology > Progesterone > Clinical EffectsInfertility > Female Factor > Ovulatory DysfunctionReproductive Endocrinology > Estrogen > Clinical Effects

Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial
Vitale SG et al., 2020 International Journal of Food Sciences and Nutrition

This study aims to evaluate the effects of myo-inositol supplementation on gestational diabetes mellitus (GDM) rates and body water distribution in overweight non-obese women. 223 overweight non-obese...

Pregnancy > Outcomes > ComplicationsReproductive Endocrinology > Progesterone > Clinical EffectsGeneral OB/GYN > Clinical Practice > Guidelines

Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial
D'Anna R et al., 2015 Obstetrics and Gynecology

Objective: To evaluate whether myo-inositol supplementation, an insulin sensitizer, reduces the rate of gestational diabetes mellitus (GDM) and lowers insulin resistance in obese pregnant women. Metho...

Pregnancy > Outcomes > ComplicationsPCOS > Treatment > PharmacologicalReproductive Endocrinology > Progesterone > Clinical Effects